Zomedica Pharmaceuticals Corp.(ZOM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ZOM Zomedica Pharmaceuticals Corp.

Market Closed 12-20 16:00:00 EST

0.1253

+0.0053

+4.42%

盘后0.1224

-0.0029-2.31%

19:58 EST

High0.1253	Low0.1196	Vol6.69M
Open0.1197	D1 Closing0.1200	Amplitude4.75%
Mkt Cap122.79M	Tradable Cap120.50M	Total Shares979.95M
T/O807.91K	T/O Rate0.70%	Tradable Shares961.66M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"ZOM","market":"US","secType":"STK","nameCN":"Zomedica Pharmaceuticals Corp.","latestPrice":0.1253,"timestamp":1734728400000,"preClose":0.12,"halted":0,"volume":6688468,"hourTrading":{"tag":"盘后","latestPrice":0.1224,"preClose":0.1253,"latestTime":"19:58 EST","volume":173058,"amount":20929.05605,"timestamp":1734742716334},"delay":0,"floatShares":961657143,"shares":979949668,"eps":-0.063466,"marketStatus":"Market Closed","change":0.0053,"latestTime":"12-20 16:00:00 EST","open":0.1197,"high":0.1253,"low":0.1196,"amount":807913.694195,"amplitude":0.0475,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.063466,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1734944400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"AMEX","adjPreClose":0.12,"preHourTrading":{"tag":"盘前","latestPrice":0.1199,"preClose":0.12,"latestTime":"09:29 EST","volume":187870,"amount":22437.749958,"timestamp":1734704993875},"postHourTrading":{"tag":"盘后","latestPrice":0.1224,"preClose":0.1253,"latestTime":"19:58 EST","volume":173058,"amount":20929.05605,"timestamp":1734742716334},"volumeRatio":1.097238739254072},"requestUrl":"/m/hq/s/ZOM/tweets","defaultTab":"tweets","newsList":[{"id":"2492436777","title":"Zomedica Appoints New CFO to Drive Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2492436777","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492436777?lang=en_us&edition=fundamental","pubTime":"2024-12-20 07:38","pubTimestamp":1734651538,"startTime":"0","endTime":"0","summary":"Zomedica Pharmaceuticals (ZOM) has released an update. Zomedica Pharmaceuticals has appointed Scott A. Jordan as Executive Vice President, Finance ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/zomedica-appoints-new-cfo-to-drive-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/zomedica-appoints-new-cfo-to-drive-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ZOM","BK4082"],"gpt_icon":0},{"id":"2492070179","title":"Zomedica Names Scott Jordan CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2492070179","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492070179?lang=en_us&edition=fundamental","pubTime":"2024-12-19 22:41","pubTimestamp":1734619305,"startTime":"0","endTime":"0","summary":"Zomedica  said Thursday it has named Scott Jordan chief financial officer and executive vice president of finance, effective Jan. 1.Jordan succeeds Peter Donato, who left the company in August, Zomedica said.Jordan previously served as the chief executive and founder of S. Jordan Associates, the company said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4082","ZOM"],"gpt_icon":0},{"id":"2492256001","title":"Zomedica Appoints Scott a. Jordan Executive Vice President, Finance & Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2492256001","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492256001?lang=en_us&edition=fundamental","pubTime":"2024-12-19 19:31","pubTimestamp":1734607898,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nFWN3NK0GX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ZOM","BK4082"],"gpt_icon":0},{"id":"2492125931","title":"Zomedica Corp - Jordan Succeeds Peter Donato","url":"https://stock-news.laohu8.com/highlight/detail?id=2492125931","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492125931?lang=en_us&edition=fundamental","pubTime":"2024-12-19 19:31","pubTimestamp":1734607898,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nFWN3NK0GX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","ZOM"],"gpt_icon":0},{"id":"2492126427","title":"Zomedica Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2492126427","media":"ACCESSWIRE","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492126427?lang=en_us&edition=fundamental","pubTime":"2024-12-19 19:30","pubTimestamp":1734607800,"startTime":"0","endTime":"0","summary":"Seasoned executive brings a broad skill set to Zomedica's leadership team. ANN ARBOR, MI / ACCESSWIRE / December 19, 2024 / Zomedica Corp.  , a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, announced that it has appointed Scott A. Jordan as its Executive Vice President, Finance and Chief Financial Officer, effective January 1, 2025.Prior to joining Zomedica, Scott Jordan was the CEO and Founder of S. Jordan Associates , a boutique investment bank headquartered in Chicago, Illinois, where Scott worked with life sciences and diagnostics companies to raise non-dilutive capital and private placements, close strategic partnerships, and facilitate listings on public stock exchanges.Scott Jordan commented, \"I am honored to join Zomedica at such an exciting time in the company's evolution,\" said Mr. Jordan. \"Zomedica's commitment to improving animal health through innovative solutions resonates deeply with me. I look forward to lev","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/9bov66OKbErabpVlcYzNfA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/4ffd0ea9ae13cf2010e5589cbaefbd3f","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/9bov66OKbErabpVlcYzNfA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/4ffd0ea9ae13cf2010e5589cbaefbd3f"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zomedica-appoints-scott-jordan-executive-113000968.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ZOM","BK4082"],"gpt_icon":0},{"id":"2486840199","title":"Zomedica to Present at the NobleCon20 Twentieth Annual Emerging Growth Equity Conference December 4, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2486840199","media":"ACCESSWIRE","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486840199?lang=en_us&edition=fundamental","pubTime":"2024-11-27 19:30","pubTimestamp":1732707000,"startTime":"0","endTime":"0","summary":"ANN ARBOR, MI / ACCESSWIRE / November 27, 2024 / Zomedica Corp.  , a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced that its Chief Executive Officer, Larry Heaton, will present and host one-on-one meetings with investors at NobleCon20 - Noble Capital Markets' Twentieth Annual Emerging Growth Equity Conference at Florida Atlantic University, Executive Education Complex, in Boca Raton, Florida on Wednesday, December 4, 2025 at 11:00 am Eastern Standard Time.Established in 1984, Noble Capital Markets is an SEC / FINRA registered full-service investment bank and advisory firm with an award-winning research team and proprietary investor distribution platform. We deliver middle market exp","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zomedica-present-noblecon20-twentieth-annual-113000431.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","EQR","BK4588","BK4215","ZOM"],"gpt_icon":0},{"id":"2483875152","title":"Zomedica Launches Quantitative Insulin Assay for Equine Plasma on the TRUFORMA(R) Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2483875152","media":"ACCESSWIRE","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483875152?lang=en_us&edition=fundamental","pubTime":"2024-11-14 19:30","pubTimestamp":1731583800,"startTime":"0","endTime":"0","summary":"Combined with Zomedica's eACTH assay, equine veterinarians get same day answers for their PPID and EMS patients. ANN ARBOR, MI / ACCESSWIRE / November 14, 2024 / Zomedica Corp.  , a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced the launch of its third equine-focused assay - Insulin for equine plasma - for the TRUFORMA In-Clinic Biosensor Testing Platform.T.J. Barclay, DVM, a Zomedica Professional Services Veterinarian, commented, \"Early identification of horses with insulin dysregulation is key in preventing hyperinsulinemia-associated laminitis. The TRUFORMA insulin assay delivers that critical information within minutes. The combination of TRUFORMA's insulin and eACTH assays can provide the veterinarian with a complete understanding of the patient's laminitis risk, allowing treatment decisions to be made on the spot.\". Zomedica is a leading equine and companion animal healthcare company dedicate","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/9bov66OKbErabpVlcYzNfA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/4ffd0ea9ae13cf2010e5589cbaefbd3f","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/9bov66OKbErabpVlcYzNfA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/4ffd0ea9ae13cf2010e5589cbaefbd3f"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zomedica-launches-quantitative-insulin-assay-113000912.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4232","BK4022","BK4082","R","ZOM"],"gpt_icon":0},{"id":"2482707515","title":"Sidoti Events, LLC's Virtual November Micro-Cap Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2482707515","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482707515?lang=en_us&edition=fundamental","pubTime":"2024-11-12 21:30","pubTimestamp":1731418200,"startTime":"0","endTime":"0","summary":"About Sidoti Events, LLC  and Sidoti & Company, LLC In 2023, Sidoti & Company, LLC  formed an affiliate company, Sidoti Events, LLC in order to focus exclusively on its rapidly growing conference business and to more directly serve the needs of presenters and attendees. The relationship allows Events to draw on the 25 years of experience Sidoti has as a premier provider of independent securities research focused specifically on small and microcap companies and the institutions that invest in their securities, with most of its coverage in the $200 million-$5 billion market cap range. Sidoti's coverage universe comprises approximately 150 equities of which greater th","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/WM1Y3nX1YGcyl.b6Y7EaZQ--~B/aD0yNDE7dz05ODQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/8c4614d356278d47c1f30ef4e5b87d5a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/WM1Y3nX1YGcyl.b6Y7EaZQ--~B/aD0yNDE7dz05ODQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/8c4614d356278d47c1f30ef4e5b87d5a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sidoti-events-llcs-virtual-november-133000213.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CRVO","GIFI","ZEUS","ALCO","SNCR","WINT","NGS","USEG","CVEO","CYRB","HYLN","MEC","RELL","PETS","ECRAF","ULY","BRLT","ATRA","HTCR","ZAPP","BK4229","TWIN","BEEP","BK4139","IRMD","BTTR","RAIL","BLGO","TRX","PRENW","PRE","OBIO","CRGOW","ZOM","PYPD","GAIA","OWLT","PERF","UJOGF","SEVCF","URG","NATR","CRGO","ANIX","LFVN","BK4156","SLVR","RZLV","VIOT","BETR","KLNG"],"gpt_icon":0},{"id":"2482770157","title":"Noble Capital Markets Initiates Equity Research Coverage on Zomedica","url":"https://stock-news.laohu8.com/highlight/detail?id=2482770157","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482770157?lang=en_us&edition=fundamental","pubTime":"2024-11-12 19:30","pubTimestamp":1731411000,"startTime":"0","endTime":"0","summary":"ANN ARBOR, MI / ACCESSWIRE / November 12, 2024 / Zomedica Corp. , a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, is pleased to announce that Noble Capital Markets has initiated company-sponsored equity research coverage on the Company. The full report by Noble Capital Markets Research Analyst Robert LeBoyer, as well as news and advanced market data on Zomedica Corp., is available on Channelchek.Channelchek  is a comprehensive investor-centric portal - featuring more than 6,000 emerging growth companies - that provides advanced market data, independent research, balanced news, video webcasts, exclusive c-suite interviews, and access to virtual road shows. The site is available to the public at every level without cost or oblig","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/noble-capital-markets-initiates-equity-113000750.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","BK4215","ZOM","EQR","BK4585","NBL"],"gpt_icon":1},{"id":"2482781795","title":"Zomedica Positioned for Growth with Strategic Acquisitions and Strong Financial Performance: Buy Recommendation","url":"https://stock-news.laohu8.com/highlight/detail?id=2482781795","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482781795?lang=en_us&edition=fundamental","pubTime":"2024-11-11 21:26","pubTimestamp":1731331562,"startTime":"0","endTime":"0","summary":"Robert LeBoyer, an analyst from Noble Financial, has initiated a new Buy rating on Zomedica Pharmaceuticals (ZOM). Robert LeBoyer’s rating is based...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/zomedica-positioned-for-growth-with-strategic-acquisitions-and-strong-financial-performance-buy-recommendation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/zomedica-positioned-for-growth-with-strategic-acquisitions-and-strong-financial-performance-buy-recommendation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","ZOM"],"gpt_icon":0},{"id":"2482047454","title":"Zomedica’s Revenue Up 10% Amid Global Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2482047454","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482047454?lang=en_us&edition=fundamental","pubTime":"2024-11-09 06:09","pubTimestamp":1731103747,"startTime":"0","endTime":"0","summary":"Zomedica Pharmaceuticals (ZOM) has released an update. Zomedica Pharmaceuticals reported a 10% revenue increase to $7 million in the third quarter ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/zomedicas-revenue-up-10-amid-global-expansion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/zomedicas-revenue-up-10-amid-global-expansion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","ZOM"],"gpt_icon":0},{"id":"2482347874","title":"Zomedica Corp (ZOM) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2482347874","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482347874?lang=en_us&edition=fundamental","pubTime":"2024-11-09 03:02","pubTimestamp":1731092576,"startTime":"0","endTime":"0","summary":"Revenue: $7 million, an increase of 10.2% year-over-year.Therapeutic Device Revenue: $6.5 million, up 8.5% driven by PulseVet's 24.5% growth.Diagnostics Segment Revenue: Approximately $500,000, an increase of 38%.Gross Margin: 72.3%, higher than last year's 69%.Net Loss: $6.7 million, or 0.007 cents per share.Cash and Equivalents: $77.8 million at the end of the quarter.GuruFocus has detected 1 Warning Sign with ZOM.Zomedica Corp  reported a strong third quarter with double-digit top-line growth and solid gross margins.Zomedica Corp  experienced disruptions in the sales force due to unexpected medical leaves, impacting capital sales in the second quarter.A: We are confident in increasing revenues across all product segments. This is the 14th consecutive quarter of record revenue levels, and we expect this trend to continue into 2025. We will provide credible guidance in the new year. - Mike Zuehlke, Vice President of Finance, Corporate Controller","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zomedica-corp-zom-q3-2024-190256725.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ZOM"],"gpt_icon":1},{"id":"2481175312","title":"Zomedica to Present at the Sidoti Micro Cap Conference November 14, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2481175312","media":"ACCESSWIRE","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481175312?lang=en_us&edition=fundamental","pubTime":"2024-11-08 19:30","pubTimestamp":1731065400,"startTime":"0","endTime":"0","summary":"ANN ARBOR, MI / ACCESSWIRE / November 8, 2024 / Zomedica Corp.  , a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced that Larry Heaton, Chief Executive Officer, will present and host one-on-one meetings with investors at the Sidoti Micro Cap Conference, taking place on November 13-14, 2024.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/9bov66OKbErabpVlcYzNfA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/4ffd0ea9ae13cf2010e5589cbaefbd3f","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/9bov66OKbErabpVlcYzNfA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/4ffd0ea9ae13cf2010e5589cbaefbd3f"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zomedica-present-sidoti-micro-cap-113000983.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ZOM"],"gpt_icon":0},{"id":"2481168251","title":"Zomedica Q3 EPS $(0.01), Sales $7.00M Up From $6.35M YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2481168251","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481168251?lang=en_us&edition=fundamental","pubTime":"2024-11-08 06:15","pubTimestamp":1731017715,"startTime":"0","endTime":"0","summary":"Zomedica (AMEX:ZOM) reported quarterly losses of $(0.01) per share.  The company reported $7.00 million in sales this quarter. This is a 10.24 percent increase over sales of $6.35 million the same period last year.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41827990/zomedica-q3-eps-0-01-sales-7-00m-up-from-6-35m-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Zomedica Q3 EPS $(0.01), Sales $7.00M Up From $6.35M YoY","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZOM"],"gpt_icon":0},{"id":"2481809190","title":"Zomedica Announces Third Quarter 2024 Financial Results: Revenue Up 10% to $7 Million; 72% Gross Margin, and $78 Million in Liquidity to Support Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2481809190","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481809190?lang=en_us&edition=fundamental","pubTime":"2024-11-08 05:25","pubTimestamp":1731014700,"startTime":"0","endTime":"0","summary":"ANN ARBOR, MI / ACCESSWIRE / November 7, 2024 / Zomedica Corp.  , a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today reported consolidated financial results for the third quarter ended September 30, 2024.\"We are very pleased with our performance, highlighted by record third quarter revenue and a double-digit increase compared to last year, which demonstrates that the execution of our growth initiatives has continued to pay dividends. As expected, PulseVet capital sales rebounded during the third quarter bolstered by a full-strength sales team in the U.S. and continued positive utilization trends among existing customers. This helped to drive strong Capital revenue growth, which we believe is a positive leading indicator of future consumable sales growth. The strength of the PulseVet line was complemented by 38% growth in our Diagnostics segment, led by the continued adoption of our TRUFORMA product line,\" comme","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/9bov66OKbErabpVlcYzNfA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/4ffd0ea9ae13cf2010e5589cbaefbd3f","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/9bov66OKbErabpVlcYzNfA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/4ffd0ea9ae13cf2010e5589cbaefbd3f"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zomedica-announces-third-quarter-2024-212500676.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ZOM"],"gpt_icon":0},{"id":"2477688908","title":"Zomedica Launches Ear Cytology Quick Scan Protocol for TRUVIEW(TM) Digital Microscope & Telepathology Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2477688908","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477688908?lang=en_us&edition=fundamental","pubTime":"2024-10-24 18:30","pubTimestamp":1729765800,"startTime":"0","endTime":"0","summary":"New Ear Cytology protocol significantly improves veterinary practice workflow by reducing total time to perform common diagnostic procedure. ANN ARBOR, MI / ACCESSWIRE / October 24, 2024 / Zomedica Corp.  , a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today announced the release of the Ear Cytology Quick Scan protocol, a new feature available on the TRUVIEW microscope equipped with the TRUprep automated slide preparation system. This innovative feature streamlines the slide preparation and scanning of ear cytology cases, allowing veterinary professionals to diagnose and treat companion animals faster and more efficiently.The Ear Cytology Quick Scan protocol enables veterinarians to complete the slide preparation and review of commonly performed ear cytology cases in just over four minutes, dramatically improving both speed and workflow. This feature is particularly beneficial for clinics that handle a high volu","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/9bov66OKbErabpVlcYzNfA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/4ffd0ea9ae13cf2010e5589cbaefbd3f","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/9bov66OKbErabpVlcYzNfA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/4ffd0ea9ae13cf2010e5589cbaefbd3f"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zomedica-launches-ear-cytology-quick-103000370.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ZOM","CAGR","03160","BK4159","BK4588","BK4099","BK4555","TM","BK4082","BK4585"],"gpt_icon":0},{"id":"2477590952","title":"Zomedica to Report Third Quarter 2024 Financial Results and Provide Business Update on November 7th at 4:30 p.m. ET","url":"https://stock-news.laohu8.com/highlight/detail?id=2477590952","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477590952?lang=en_us&edition=fundamental","pubTime":"2024-10-24 07:20","pubTimestamp":1729725600,"startTime":"0","endTime":"0","summary":"ANN ARBOR, MI / ACCESSWIRE / October 23, 2024 / Zomedica Corp.  , a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, will host a conference call and audio-only webcast on Thursday, November 7, 2024, at 4:30 p.m. ET to discuss the Company's operational and financial highlights for its thirdquarter ended September 30, 2024. A question-and-answer session will follow management's prepared remarks.Event: Zomedica Corp. Q3 2024 Financial Results Conference Call. For interested individuals unable to join the conference call, a dial-in replay of the call will be available until Thursday, November 21, 2024 at 11:59 PM ET and can be accessed by dialing +1-844-512-2921  or +1-412-317-6671  and entering replay pin number: 1120247","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/9bov66OKbErabpVlcYzNfA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/4ffd0ea9ae13cf2010e5589cbaefbd3f","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/9bov66OKbErabpVlcYzNfA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/4ffd0ea9ae13cf2010e5589cbaefbd3f"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zomedica-report-third-quarter-2024-232000679.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","BK4581","ET","BK4585","BK4561","ZOM","BK4590","BK4144"],"gpt_icon":0},{"id":"2475576846","title":"Zomedica Announces Sponsorship of Educational Presentations at the Fetch Coastal Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2475576846","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475576846?lang=en_us&edition=fundamental","pubTime":"2024-10-15 18:30","pubTimestamp":1728988200,"startTime":"0","endTime":"0","summary":"Leading veterinary experts to present educational programs featuring Zomedica product applications at the Fetch dvm360 Veterinary Conference. Kevin Klass, Zomedica's Senior Vice President of Sales, elaborated, \"At Fetch Coastal, we have the unique opportunity to demonstrate how our suite of products addresses real-world veterinary challenges. The TRUFORMA Bulk Acoustic Wave diagnostic platform, TRUVIEW fully automated digital microscope, PulseVet shock wave platform, and VETGuardian zero-touch remote monitor continue to break new ground with innovative applications and expansion into global markets. This conference allows us to not just tell, but also show veterinarians how these tools can transform their daily practice and elevate the standard of care they provide.\". About ZomedicaZomedica is a leading equine and companion animal healthcare company dedicated to improving animal health by providing veterinarians innovative therapeutic and diagnostic solutions. Our gold standard PulseVe","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/9bov66OKbErabpVlcYzNfA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/4ffd0ea9ae13cf2010e5589cbaefbd3f","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/9bov66OKbErabpVlcYzNfA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/4ffd0ea9ae13cf2010e5589cbaefbd3f"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zomedica-announces-sponsorship-educational-presentations-103000022.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ZOM"],"gpt_icon":0},{"id":"2474852667","title":"Zomedica Corp (ZOM) Q2 2024 Earnings Call Highlights: Diagnostics Surge Amid Revenue Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2474852667","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474852667?lang=en_us&edition=fundamental","pubTime":"2024-10-10 06:24","pubTimestamp":1728512653,"startTime":"0","endTime":"0","summary":"Revenue: $6.1 million, a 2% increase over Q2 2023.Gross Profit Margin: 71%, up from 67% in the previous year.Net Loss: $23.9 million, or $0.024 per share.Cash Position: $83 million in cash, cash equivalents, and available-for-sale securities.Consumable Revenue: $4.4 million, representing 72% of total revenue.Capital Revenue: $1.7 million, down 12% from the previous year.Operating Expenses : $13.4 million, up from $10.8 million in Q2 2023.Non-GAAP EBITDA Loss: $22.3 million, adjusted to $5.2 million for non-cash and nonrecurring items.GuruFocus has detected 1 Warning Sign with ZOM.For the complete transcript of the earnings call, please refer to the full earnings call transcript.Zomedica Corp  reported a 68% year-over-year growth in its diagnostics segment, driven by new assay launches and demand for VETGuardian.PulseVet consumables revenue grew by 11%, indicating strong repeat usage by customers and highlighting the product's value.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zomedica-corp-zom-q2-2024-222413767.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ZOM"],"gpt_icon":0},{"id":"2472699024","title":"Zomedica Expands Distribution Agreement With Grovet for 27 European Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2472699024","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472699024?lang=en_us&edition=fundamental","pubTime":"2024-10-03 19:28","pubTimestamp":1727954901,"startTime":"0","endTime":"0","summary":"Zomedica  said Thursday it has expanded its distribution partnership with European equine veterinary distributor Grovet.Under the agreement, Grovet will have exclusive distribution rights for Zomedica's equine products, including the PulseVet and TRUFORMA product platforms, across 27 European countries. The distribution in Italy and the UK will be on a non-exclusive basis.Zomedica already had an agreement with Grovet for the distribution of the PulseVet products.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ZOM","BK4082"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zomedica.com","stockEarnings":[{"period":"1week","weight":0.0187},{"period":"1month","weight":-0.045},{"period":"3month","weight":-0.08},{"period":"6month","weight":-0.1412},{"period":"1year","weight":-0.422},{"period":"ytd","weight":-0.3741}],"compareEarnings":[{"period":"1week","weight":-0.0216},{"period":"1month","weight":0.0011},{"period":"3month","weight":0.0403},{"period":"6month","weight":0.0857},{"period":"1year","weight":0.2506},{"period":"ytd","weight":0.2437}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system. It also provides therapeutic products, including PulseVet electrohydraulic shockwave therapy platform; and Assisi Loop line of products, including the Assisi Loop, Assisi Loop Lounge, and DentaLoop devices that treat pain and inflammation through delivery of targeted pulsed electromagnetic field focused energy. The company has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for the development of a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. is headquartered in Ann Arbor, Michigan.","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.381112},{"month":2,"riseRate":0.857143,"avgChangeRate":0.21916},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.15261},{"month":4,"riseRate":0.142857,"avgChangeRate":-0.097509},{"month":5,"riseRate":0.142857,"avgChangeRate":-0.067042},{"month":6,"riseRate":0.428571,"avgChangeRate":0.035582},{"month":7,"riseRate":0.571429,"avgChangeRate":-0.038541},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.024783},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.063692},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.098855},{"month":11,"riseRate":0.428571,"avgChangeRate":0.132985},{"month":12,"riseRate":0.25,"avgChangeRate":-0.018588}],"exchange":"AMEX","name":"Zomedica Pharmaceuticals Corp.","nameEN":"Zomedica Pharmaceuticals Corp."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Zomedica Pharmaceuticals Corp.(ZOM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Zomedica Pharmaceuticals Corp.(ZOM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Zomedica Pharmaceuticals Corp.,ZOM,Zomedica Pharmaceuticals Corp.股票,Zomedica Pharmaceuticals Corp.股票老虎,Zomedica Pharmaceuticals Corp.股票老虎国际,Zomedica Pharmaceuticals Corp.行情,Zomedica Pharmaceuticals Corp.股票行情,Zomedica Pharmaceuticals Corp.股价,Zomedica Pharmaceuticals Corp.股市,Zomedica Pharmaceuticals Corp.股票价格,Zomedica Pharmaceuticals Corp.股票交易,Zomedica Pharmaceuticals Corp.股票购买,Zomedica Pharmaceuticals Corp.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Zomedica Pharmaceuticals Corp.(ZOM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Zomedica Pharmaceuticals Corp.(ZOM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}